Vital Images and Toshiba restructure deal:
This article was originally published in Clinica
Toshiba's medical systems business is to sell Vital Images' Vitrea 2 software through its subsidiaries and distributors in North and South America, Europe, the Middle East, Africa, Australia and Asia, excluding Japan. The deal, which includes a minimum worldwide revenue commitment of $4 million, supersedes and extends a deal between Minneapolis-based Vital Images and the US subsidiary of Toshiba, Toshiba America Medical Systems (TAMS). The new deal covers only higher-margin software and services, while under the original deal TAMS bought the hardware platform as well as software and services.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.